Release Date: 25/10/12 11:10 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 276.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%